Xin Tian

981 citations
34 papers · 246 indexed · h-index 10
Topics
Neuroblastoma Research and Treatments (5 papers)Acute Lymphoblastic Leukemia research (4 papers)Drug-Induced Adverse Reactions (3 papers)

In The Last Decade

Xin Tian

29 papers receiving 241 citations

Peers

Xin Tian
Comparison fields: 5 of 77
  • Molecular Biology 69
  • Pharmacology 37
  • Surgery 31
  • Genetics 30
  • Physiology 30
Replace Luz María Torres‐Espíndola with:
Luz María Torres‐Espíndola Mexico
Rebeca Rodríguez‐Pena Spain
Frank Fliegert Germany
N. Ansorge Germany
Yun‐Ru Liu Taiwan
Andrew Li China
Peiying Zuo United States
Mirjam E. van de Velde Netherlands
Misba Beerahee United Kingdom
Shinitsu Hatakeyama Japan
Xin Tian relative to Luz María Torres‐Espíndola Mexico Luz María Torres‐Espíndola's profile →
Citations per field
00.5×3.5×
Luz María Torres‐Espíndola · 1×
Citations per year

Countries citing papers authored by Xin Tian

Since Specialization
Citations

This map shows the geographic impact of Xin Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Tian more than expected).

Fields of papers citing papers by Xin Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Tian. The network helps show where Xin Tian may publish in the future.

Co-authorship network of co-authors of Xin Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Tian. A scholar is included among the top collaborators of Xin Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Tian. Xin Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 0
5 4
6 0
7 3
8 1
9 2
10 7
11 4
12 20
13 16
14 7
15 9
16 4
17 9
18 4
19 41
20
[The study of autoantibodies in women with habitual abortion of unknown etiology].
1

About Xin Tian

Xin Tian is a scholar working on Hematology, Critical Care and Intensive Care Medicine and Genetics, having authored 34 papers that have together received 246 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Drug-Induced Adverse Reactions (3 papers). The work is most often cited by research in Gastroenterology (20 citations), Pharmacology (28 citations) and Genetics (30 citations). Xin Tian has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hai–Ling Qiao, Lin-Jing Jia, Na Gao, Lirong Zhang, Yurong Hu, Xueshan Xia, Hongchao Jiang, Li Jiang, Qiang Wen and Na Li. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026